REMA BECOMES FIRST AFRICAN ARTIST ON ROLLING STONE COVER. (PHOTO).

Image
 Rema Becomes First African Artist on Rolling Stone Cover Nigerian music star Divine Ikubor, popularly known as Rema, has made history as the first African artist to be featured on the cover of Rolling Stone magazine. The American publication, renowned for its coverage of music, politics, and pop culture, announced Rema as the cover star for its April 2025 edition. Mavin Records celebrated the achievement on Instagram, calling him the “Afrobeats Visionary.” Following the announcement, Rema delivered an electrifying performance at the Rolling Stone concert, thrilling audiences with hits like Dumebi, Woman, and Calm Down. This milestone further solidifies Rema’s influence in global music, coming shortly after his feature on Dazed magazine. Since rising to fame in 2019 under Mavin Records, Rema has continued to push Afrobeats to new heights. His hit song Calm Down, featuring Selena Gomez, became the most streamed Afrobeats track in history, surpassing a billion streams on Spotify and ...

FDA APPROVES CLINICAL TRIALS FOR PIG KIDNEY TRANSPLANTS IN HUMANS. (PHOTO).


 FDA Approves Clinical Trials for Pig Kidney Transplants in Humans


The US Food and Drug Administration has greenlit clinical trails for organ transplants from genetically modified pigs. The study led by United Therapeutics Corp will begin with six patients facing end-stage renal disease — eventually being expanded to include 50 kidney failure patients. The first transplant is expected to occur in mid-2025.

According to a statement released by the company on Monday, patients will receive a UKidney transplant followed by a 24-week post-transplant follow-up period. Participants will continue to be followed for the rest of their lives — including for survival, UKidney function, and monitoring for zoonotic infections4 — during this time.


The first cohort will comprise of six transplants at two centers — with a 12-week waiting period between the first and second transplants. Data will be reviewed after this group of patients reaches at least 12 weeks post-transplant in order to determine whether the study should continue. 

United Therapeutics has also indicated plants to engage with the FDA after the first six transplants are completed. If safety and efficacy results are supportive, the sample size will be increased to a total of up to 50 participants to enable the study to support registration, with additional transplant centers expected to be added to the study.


The studies could be a breakthrough for people needing a kidney transplant. More than 37 million Americans are estimated to have chronic kidney disease, according to 2021 data from the US Centers for Disease Control and Prevention. Patients in need of a kidney transplant can wait for as long as five years before the procedure, with a risk of complications arising during that time. An estimated 12 people die each day while waiting for a kidney, according to the National Kidney Foundation.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

ACTOR BABA IJESHA APPEALS FIVE-YEAR JAIL SENTENCE FOR SEXUAL ASSAULT. (PHOTO).